Laparoscopic Hepatic Resection Versus Laparoscopic Radiofrequency Ablation for Subcapsular Hepatocellular Carcinomas Smaller Than 3 cm: Analysis of Treatment Outcomes Using Propensity Score Matching

• Published in: Korean journal of radiology Vol. 23; no. 6; pp. 615 - 624
• Main Authors: Ko, Seong Eun, Lee, Min Woo, Ahn, Soohyun, Rhim, Hyunchul, Kang, Tae Wook, Song, Kyoung Doo, Kim, Jong Man, Choi, Gyu-Seong, Cha, Dong Ik, Min, Ji Hye, Sinn, Dong Hyun, Choi, Moon Seok, Lim, Hyo Keun
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Society of Radiology 01.06.2022; 대한영상의학회
• Subjects: Ablation; Clinical outcomes; Electrodes; Gastrointestinal Imaging; Laparoscopy; Liver cancer; Patients; Tumors; 방사선과학; Radiofrequency ablation; Hepatocellular carcinoma; Laparoscopy; Resection; Survival
• ISSN: 1229-6929; 2005-8330
• DOI: 10.3348/kjr.2021.0786

To compare the therapeutic outcomes of laparoscopic hepatic resection (LHR) and laparoscopic radiofrequency ablation (LRFA) for single subcapsular hepatocellular carcinoma (HCC). We screened 244 consecutive patients who had received either LHR or LRFA between January 2014 and December 2016. The feasibility of LRFA in patients who underwent LHR was retrospectively assessed by two interventional radiologists. Finally, 60 LRFA-feasible patients who had received LHR and 29 patients who had received LRFA as the first treatment for a solitary subcapsular HCC between 1 cm and 3 cm were finally included. We compared the therapeutic outcomes, including local tumor progression (LTP), recurrence-free survival (RFS), and overall survival (OS) between the two groups before and after propensity score (PS) matching. Multivariable Cox proportional hazard regression was also used to evaluate the difference in OS and RFS between the two groups for all 89 patients. PS matching yielded 23 patients in each group. The cumulative LTP and OS rates were not significantly different between the LHR and LRFA groups after PS matching ( = 0.900 and 0.003, respectively). The 5-year LTP rates were 4.6% and 4.4%, respectively, and OS rates were 100% and 90.7%, respectively. The RFS rate was higher in LHR group without statistical significance ( = 0.070), with 5-year rates of 78.3% and 45.3%, respectively. OS was not significantly different between the LHR (reference) and LRFA groups in multivariable analyses, with a hazard ratio (HR) of 1.33 (95% confidence interval, 0.12-1.54) ( = 0.818). RFS was higher in LHR (reference) than in LRFA without statistical significance in multivariable analysis, with an HR of 2.01 (0.87-4.66) ( = 0.102). There was no significant difference in therapeutic outcomes between LHR and LRFA for single subcapsular HCCs measuring 1-3 cm. The difference in RFS should be further evaluated in a larger study.